CME credits: 0.50

Valid until: 28-02-2025

Claim your CME credit at https://reachmd.com/programs/cme/practical-management-of-variceal-bleeding-and-hepatorenal-syndrome/15771/

Extrahepatic manifestations of decompensated cirrhosis confer significant additional risks for mortality, and a multidisciplinary team of healthcare professionals is involved in the care of these patients. This program will discuss two critical aspects of advanced liver disease: variceal bleeding and hepatorenal syndrome (HRS). These complications pose significant challenges in the management of patients with cirrhosis. Clinically-significant portal hypertension, identified by a hepatic venous pressure gradient >10mmHg, predicts the development of variceal hemorrhage, hepatic encephalopathy, ascites, and HRS, all hallmarks of decompensation and multi-organ failure. Faculty will discuss a common patient presentation to highlight best practices in evidence-based care of patients with variceal bleeding and HRS/acute kidney injury.

=

CME credits: 1.50

Valid until: 27-02-2025

Claim your CME credit at https://reachmd.com/programs/cme/emerging-data-in-the-management-of-acute-ischemic-stroketia/18133/

This program addresses critical gaps in healthcare professionals' knowledge and practice related to the secondary prevention of a clot-related stroke in patients with an acute ischemic stroke or at high risk for TIA. By addressing these gaps and achieving the outlined learning objectives, participants will be better equipped to provide optimal patient care, ultimately improving outcomes in managing this critical medical condition.

CME credits: 1.50

Valid until: 27-02-2025

Claim your CME credit at https://reachmd.com/programs/cme/preventing-ischemic-stroke-in-todays-world/18130/

This program addresses critical gaps in healthcare professionals' knowledge and practice related to the secondary prevention of a clot-related stroke in patients with an acute ischemic stroke or at high risk for TIA. By addressing these gaps and achieving the outlined learning objectives, participants will be better equipped to provide optimal patient care, ultimately improving outcomes in managing this critical medical condition.

CME credits: 1.50

Valid until: 27-02-2025

Claim your CME credit at https://reachmd.com/programs/cme/the-frontier-of-stroke-diagnosis-rapidai-how-can-artificial-intelligence-improve-acute-care-for-ischemic-and-hemorrhagic-stroke/18129/

Join experts and explore an exciting new frontier of care for patients on direct oral anticoagulants who present with an intracranial hemorrhage. Three factors can be used to optimize treatment: emerging data on anticoagulation reversal, artificial intelligence utilization, and evidence-based ABC care bundling. Learn how these developments transform clinical practice, deepen institutional expertise, and ultimately improve patient outcomes.

CME credits: 1.50

Valid until: 27-02-2025

Claim your CME credit at https://reachmd.com/programs/cme/emerging-data-in-the-management-of-intracranial-hemorrhage-in-the-anticoagulated-patient/18128/

Join experts and explore an exciting new frontier of care for patients on direct oral anticoagulants who present with an intracranial hemorrhage. Three factors can be used to optimize treatment: emerging data on anticoagulation reversal, artificial intelligence utilization, and evidence-based ABC care bundling. Learn how these developments transform clinical practice, deepen institutional expertise, and ultimately improve patient outcomes.

CME credits: 1.50

Valid until: 27-02-2025

Claim your CME credit at https://reachmd.com/programs/cme/abc-ich-does-care-bundling-improve-outcomes-for-patients-with-intracranial-hemorrhage/18127/

Join experts and explore an exciting new frontier of care for patients on direct oral anticoagulants who present with an intracranial hemorrhage. Three factors can be used to optimize treatment: emerging data on anticoagulation reversal, artificial intelligence utilization, and evidence-based ABC care bundling. Learn how these developments transform clinical practice, deepen institutional expertise, and ultimately improve patient outcomes.

CME credits: 1.50

Valid until: 27-02-2025

Claim your CME credit at https://reachmd.com/programs/cme/while-antiplatelets-are-goodthey-arent-for-everyone/18131/

This program addresses critical gaps in healthcare professionals' knowledge and practice related to the secondary prevention of a clot-related stroke in patients with an acute ischemic stroke or at high risk for TIA. By addressing these gaps and achieving the outlined learning objectives, participants will be better equipped to provide optimal patient care, ultimately improving outcomes in managing this critical medical condition.

CME credits: 1.50

Valid until: 27-02-2025

Claim your CME credit at https://reachmd.com/programs/cme/the-path-forward-whats-on-the-horizon/18132/

This program addresses critical gaps in healthcare professionals' knowledge and practice related to the secondary prevention of a clot-related stroke in patients with an acute ischemic stroke or at high risk for TIA. By addressing these gaps and achieving the outlined learning objectives, participants will be better equipped to provide optimal patient care, ultimately improving outcomes in managing this critical medical condition.

CME credits: 1.50

Valid until: 27-02-2025

Claim your CME credit at https://reachmd.com/programs/cme/providing-optimal-care-for-the-anticoagulated-patient-with-intracranial-hemorrhage-in-the-acute-care-setting-does-the-patient-need-reversal-repletion-or-surgery/18125/

Join experts and explore an exciting new frontier of care for patients on direct oral anticoagulants who present with an intracranial hemorrhage. Three factors can be used to optimize treatment: emerging data on anticoagulation reversal, artificial intelligence utilization, and evidence-based ABC care bundling. Learn how these developments transform clinical practice, deepen institutional expertise, and ultimately improve patient outcomes.

CME credits: 1.50

Valid until: 27-02-2025

Claim your CME credit at https://reachmd.com/programs/cme/implementation-of-the-2022-ahaasa-guideline-for-the-management-of-patients-with-spontaneous-intracerebral-hemorrhageare-you-doing-enough/18126/

Join experts and explore an exciting new frontier of care for patients on direct oral anticoagulants who present with an intracranial hemorrhage. Three factors can be used to optimize treatment: emerging data on anticoagulation reversal, artificial intelligence utilization, and evidence-based ABC care bundling. Learn how these developments transform clinical practice, deepen institutional expertise, and ultimately improve patient outcomes.